Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 821-830 of 2932 for cancer

Edit search filters
  1. Surgery With Or Without Neoadjuvant Chemotherapy In High Risk RetroPeritoneal Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Individualized Treatment In Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based On EBV DNA

    Rochester, MN

  3. Sequential Treatments Or Combinations Including Dasatinib, Quercetin, Fisetin And/or Temozolomide For The Treatment Of Previously Treated Glioma With Residual Disease

    Rochester, MN

  4. Lurbinectedin + Doxorubicin In Leiomyosarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Pivotal Study Of The NanoKnife System For The Ablation Of Prostate Tissue

    Rochester, MN

  6. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. STIMULUS MDS-US : Sabatolimab Added To HMA In Higher Risk MDS

    Scottsdale/Phoenix, AZ

  8. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma

    Rochester, MN

  10. JNJ-90301900 (NBTXR3) Activated By Radiotherapy With Or Without Cetuximab In LA-HNSCC

    Jacksonville, FL

.

Mayo Clinic Footer